Trial Profile
Linezolid Pharmacokinetics and Pharmacodynamics in the Treatment of Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Jun 2014
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Tuberculosis
- Focus Pharmacokinetics
- 11 Oct 2011 Actual initiation date changed from Dec 2009 to Apr 2009 as reported by ClinicalTrials.gov.
- 16 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 16 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.